Association Between Body Mass Index and Clinical Outcomes in Diabetic Patients Hospitalized with COVID-19
DOI:
https://doi.org/10.18502/ijdo.v18i4.23240Keywords:
COVID-19; Diabetes mellitus; Body mass index; MortalityAbstract
Objective: Diabetes mellitus increases the risk of severe coronavirus disease 2019 (COVID-19). The prognostic value of body mass index (BMI) in diabetic patients with COVID-19 remains uncertain. We investigated the association between BMI and clinical outcomes in hospitalized diabetic patients.
Materials and Methods: This retrospective cohort study included 925 adults with diabetes hospitalized for confirmed COVID-19 at Shahid Sadoughi Hospital, Yazd, Iran, from March 2020 to March 2021. Patients were grouped by BMI (<20, 20–24.9, 25–29.9, 30–34.9, and ≥35 kg/m²). Univariable and multivariable logistic regression assessed factors associated with in-hospital mortality.
Results: Mortality differed across BMI groups (P< 0.001), peaking at 21.3% in the 25–29.9 kg/m² group. Compared with BMI 20–24.9 kg/m², mortality odds were lower for BMI 30–34.9 kg/m² (adjusted OR= 0.15, 95% CI: 0.05–0.49; P= 0.002) and BMI <20 kg/m² (adjusted OR= 0.16, 95% CI: 0.04–0.73; P=0.018). Male sex (adjusted OR= 1.84, 95% CI: 1.15–2.94; P= 0.012), hypertension (adjusted OR= 2.07, 95% CI: 1.28–3.32; P= 0.003), higher LDH (adjusted OR= 1.009, 95% CI: 1.007–1.011; P< 0.001), and higher ESR (adjusted OR= 1.076, 95% CI: 1.055–1.096; P< 0.001) were associated with higher mortality, whereas higher oxygen saturation was associated with lower mortality (adjusted OR= 0.95, 95% CI: 0.91–0.997; P= 0.036).
Conclusion: BMI was non-uniformly associated with in-hospital mortality in diabetic patients with COVID- 19. Clinical and inflammatory markers were also independent predictors. Prospective multicenter studies are warranted.